General switching guidelines suggest that patients on semaglutide 0.25 to 0.5mg typically transition to tirzepatide 2.5mg
We use only sterile, medical-grade, single-use supplies that meet the same standards you'd find in a hospital setting
Race, BMI, radiation, chemotherapy history, pre-existing diagnosis of diabetes, lymphedema development after ALND, and the use of GLP-1RAs were analyzed
Its designed to be easy on your body and to kickstart your weight-loss goals
Increased plasma TMAO levels are linked to an increased risk of severe cardiovascular events and death
When considering Retatrutide vs Survodutide, Retatrutide's broader receptor engagement is a key differentiator